{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T01:28:12Z","timestamp":1786670892669,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Nature Science Foundation","award":["23ZR1453500"],"award-info":[{"award-number":["23ZR1453500"]}]},{"name":"Clinical Research Plan of SHDC","award":["No. SHDC2020R4001"],"award-info":[{"award-number":["No. SHDC2020R4001"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["No.22120240337"],"award-info":[{"award-number":["No.22120240337"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04332-0","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T18:54:14Z","timestamp":1781031254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A cilia-associated signature predicts resistance to anti-PD-1 immune checkpoint blockade therapy in lung adenocarcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Fei","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaohua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changbin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxiang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caicun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"9","key":"4332_CR1","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/jto.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 2015;10(9):1243\u201360. https:\/\/doi.org\/10.1097\/jto.0000000000000630. [published Online First: 2015\/08\/21].","journal-title":"J Thorac Oncol"},{"issue":"1","key":"4332_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","volume":"86","author":"M Riihim\u00e4ki","year":"2014","unstructured":"Riihim\u00e4ki M, Hemminki A, Fallah M, et al. Metastatic sites and survival in lung cancer. Lung Cancer. 2014;86(1):78\u201384. https:\/\/doi.org\/10.1016\/j.lungcan.2014.07.020. [published Online First: 2014\/08\/19].","journal-title":"Lung Cancer"},{"issue":"19","key":"4332_CR3","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodr\u00edguez-Abreu D, Robinson AG, et al. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. N Engl J Med. 2016;375(19):1823\u201333. https:\/\/doi.org\/10.1056\/NEJMoa1606774. [published Online First: 2016\/10\/11].","journal-title":"N Engl J Med"},{"issue":"24","key":"4332_CR4","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1056\/NEJMoa1716948","volume":"378","author":"MA Socinski","year":"2018","unstructured":"Socinski MA, Jotte RM, Cappuzzo F, et al. Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC. N Engl J Med. 2018;378(24):2288\u2013301. https:\/\/doi.org\/10.1056\/NEJMoa1716948. [published Online First: 2018\/06\/05].","journal-title":"N Engl J Med"},{"issue":"25","key":"4332_CR5","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1056\/NEJMoa1613493","volume":"376","author":"DP Carbone","year":"2017","unstructured":"Carbone DP, Reck M, Paz-Ares L, et al. First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer. N Engl J Med. 2017;376(25):2415\u201326. https:\/\/doi.org\/10.1056\/NEJMoa1613493. [published Online First: 2017\/06\/22].","journal-title":"N Engl J Med"},{"key":"4332_CR6","doi-asserted-by":"publisher","unstructured":"Cristescu R, Mogg R, Ayers M, et al. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science. 2018;362(6411). https:\/\/doi.org\/10.1126\/science.aar3593.","DOI":"10.1126\/science.aar3593"},{"key":"4332_CR7","doi-asserted-by":"publisher","unstructured":"Hellmann MD, Nathanson T, Rizvi H et al. Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer. Cancer Cell 2018;33(5):843\u2009\u2013\u200952.e4. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.018 [published Online First: 2018\/04\/17].","DOI":"10.1016\/j.ccell.2018.03.018"},{"issue":"5","key":"4332_CR8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ccell.2021.04.005","volume":"39","author":"O Klein","year":"2021","unstructured":"Klein O, Kee D, Markman B, et al. Evaluation of TMB as a predictive biomarker in patients with solid cancers treated with anti-PD-1\/CTLA-4 combination immunotherapy. Cancer Cell. 2021;39(5):592\u201393. https:\/\/doi.org\/10.1016\/j.ccell.2021.04.005. [published Online First: 2021\/05\/01].","journal-title":"Cancer Cell"},{"issue":"7963","key":"4332_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","volume":"618","author":"LA Rojas","year":"2023","unstructured":"Rojas LA, Sethna Z, Soares KC, et al. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature. 2023;618(7963):144\u201350. https:\/\/doi.org\/10.1038\/s41586-023-06063-y. [published Online First: 2023\/05\/11].","journal-title":"Nature"},{"key":"4332_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cbpa.2020.02.005","volume":"56","author":"A Bellesoeur","year":"2020","unstructured":"Bellesoeur A, Torossian N, Amigorena S, et al. Advances in theranostic biomarkers for tumor immunotherapy. Curr Opin Chem Biol. 2020;56:79\u201390. https:\/\/doi.org\/10.1016\/j.cbpa.2020.02.005. [published Online First: 2020\/03\/29].","journal-title":"Curr Opin Chem Biol"},{"issue":"1","key":"4332_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41467-022-35431-x","volume":"14","author":"S Li","year":"2023","unstructured":"Li S, Yu W, Xie F, et al. Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer. Nat Commun. 2023;14(1):8. https:\/\/doi.org\/10.1038\/s41467-022-35431-x. [published Online First: 2023\/01\/04].","journal-title":"Nat Commun"},{"key":"4332_CR12","doi-asserted-by":"publisher","unstructured":"<2023-JCO-. Functional Engagement of the PD-1_PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non\u2013Small-Cell Lung Cancer.pdf>. https:\/\/doi.org\/10.1200\/JCO.22","DOI":"10.1200\/JCO.22"},{"key":"4332_CR13","unstructured":"1200\/JCO.22.01748."},{"issue":"3","key":"4332_CR14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/odi.13791","volume":"28","author":"F Yin","year":"2022","unstructured":"Yin F, Chen Q, Shi Y, et al. Activation of EGFR-Aurora A induces loss of primary cilia in oral squamous cell carcinoma. Oral Dis. 2022;28(3):621\u201330. https:\/\/doi.org\/10.1111\/odi.13791. [published Online First: 2021\/02\/03].","journal-title":"Oral Dis"},{"issue":"6","key":"4332_CR15","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.ccr.2013.04.008","volume":"23","author":"E Kim","year":"2013","unstructured":"Kim E, Kim M, Woo DH, et al. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell. 2013;23(6):839\u201352. [published Online First: 2013\/05\/21].","journal-title":"Cancer Cell"},{"issue":"8","key":"4332_CR16","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/jcp.31092","volume":"238","author":"YT Guan","year":"2023","unstructured":"Guan YT, Zhang C, Zhang HY, et al. Primary cilia: Structure, dynamics, and roles in cancer cells and tumor microenvironment. J Cell Physiol. 2023;238(8):1788\u2013807. https:\/\/doi.org\/10.1002\/jcp.31092. [published Online First: 2023\/08\/11].","journal-title":"J Cell Physiol"},{"issue":"2","key":"4332_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026.","journal-title":"Eur J Cancer"},{"issue":"1","key":"4332_CR18","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","volume":"10","author":"H Jung","year":"2019","unstructured":"Jung H, Kim HS, Kim JY, et al. DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load. Nat Commun. 2019;10(1):4278. https:\/\/doi.org\/10.1038\/s41467-019-12159-9. [published Online First: 2019\/09\/21].","journal-title":"Nat Commun"},{"issue":"10030","key":"4332_CR19","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/s0140-6736(16)00587-0","volume":"387","author":"L Fehrenbacher","year":"2016","unstructured":"Fehrenbacher L, Spira A, Ballinger M, et al. Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial. Lancet. 2016;387(10030):1837\u201346. https:\/\/doi.org\/10.1016\/s0140-6736(16)00587-0. [published Online First: 2016\/03\/14].","journal-title":"Lancet"},{"issue":"1","key":"4332_CR20","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/s41467-021-22801-0","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu F, Fan J, He Y, et al. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer. Nat Commun. 2021;12(1):2540. https:\/\/doi.org\/10.1038\/s41467-021-22801-0. [published Online First: 2021\/05\/07].","journal-title":"Nat Commun"},{"issue":"1","key":"4332_CR21","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim N, Kim HK, Lee K, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11(1):2285. https:\/\/doi.org\/10.1038\/s41467-020-16164-1. [published Online First: 2020\/05\/10].","journal-title":"Nat Commun"},{"issue":"14","key":"4332_CR22","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1056\/NEJMoa1917346","volume":"383","author":"RS Herbst","year":"2020","unstructured":"Herbst RS, Giaccone G, de Marinis F, et al. Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC. N Engl J Med. 2020;383(14):1328\u201339. https:\/\/doi.org\/10.1056\/NEJMoa1917346. [published Online First: 2020\/10\/01].","journal-title":"N Engl J Med"},{"issue":"8","key":"4332_CR23","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/jci91190","volume":"127","author":"M Ayers","year":"2017","unstructured":"Ayers M, Lunceford J, Nebozhyn M, et al. IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade. J Clin Invest. 2017;127(8):2930\u201340. https:\/\/doi.org\/10.1172\/jci91190. [published Online First: 2017\/06\/27].","journal-title":"J Clin Invest"},{"issue":"1","key":"4332_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12967-019-1867-6","volume":"17","author":"C Zhu","year":"2019","unstructured":"Zhu C, Yang Q, Xu J, et al. Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patients. J Transl Med. 2019;17(1):109. https:\/\/doi.org\/10.1186\/s12967-019-1867-6. [published Online First: 2019\/04\/05].","journal-title":"J Transl Med"},{"key":"4332_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.lungcan.2017.10.001","volume":"113","author":"T Ichikawa","year":"2017","unstructured":"Ichikawa T, Saruwatari K, Mimaki S, et al. Immunohistochemical and genetic characteristics of lung cancer mimicking organizing pneumonia. Lung Cancer. 2017;113:134\u201339. https:\/\/doi.org\/10.1016\/j.lungcan.2017.10.001. [published Online First: 2017\/11\/08].","journal-title":"Lung Cancer"},{"issue":"3","key":"4332_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10456-020-09713-1","volume":"23","author":"EH Moon","year":"2020","unstructured":"Moon EH, Kim YH, Vu PN, et al. TMEM100 is a key factor for specification of lymphatic endothelial progenitors. Angiogenesis. 2020;23(3):339\u201355. https:\/\/doi.org\/10.1007\/s10456-020-09713-1. [published Online First: 2020\/03\/01].","journal-title":"Angiogenesis"},{"issue":"30","key":"4332_CR27","doi-asserted-by":"publisher","first-page":"12064","DOI":"10.1073\/pnas.1207210109","volume":"109","author":"S Somekawa","year":"2012","unstructured":"Somekawa S, Imagawa K, Hayashi H, et al. Tmem100, an ALK1 receptor signaling-dependent gene essential for arterial endothelium differentiation and vascular morphogenesis. Proc Natl Acad Sci U S A. 2012;109(30):12064\u20139. https:\/\/doi.org\/10.1073\/pnas.1207210109. [published Online First: 2012\/07\/12].","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4332_CR28","doi-asserted-by":"publisher","unstructured":"Yuan A, Rao MV, Veeranna, et al. Neurofilaments and Neurofilament Proteins in Health and Disease. Cold Spring Harb Perspect Biol. 2017;9(4). https:\/\/doi.org\/10.1101\/cshperspect.a018309. [published Online First: 2017\/04\/05].","DOI":"10.1101\/cshperspect.a018309"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04332-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04332-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04332-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T01:05:55Z","timestamp":1786669555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04332-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4332"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04332-0","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"13 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and approved by the Ethics Committee of Shanghai Pulmonary Hospital (K23-303). Due to the anonymized retrospective nature of the data, informed consent to participate the study was not necessary.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the anonymized retrospective nature of the data, informed consent to publish the study was not necessary.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C.B.Z., T.H., Q.L., and Z.H. were employed by Amoy Diagnostics Co., Ltd. None of the other authors have any conflicts of interest to declare.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"283"}}